Dr. Mustafa Aydgodu

About Dr. Mustafa Aydgodu

Dr. Mustafa Aydogdu is a renowned Senology and Gynaecological Oncology specialist with over 29 years of experience in breast cancer surgery, gynaecological cancer treatment, and certified breast centre leadership. As a leading Surgical Oncology specialist Bremen, Germany, he is the Klinikdirektor (Clinic Director) of the German Cancer Society (DKG)-certified Breast and Gynaecological Cancer Centre at Klinikum Bremen-Mitte and an active researcher in the Brain Metastases in Breast Cancer Registry (BMBC).

29+ years of senology, gynaecological oncology, and breast cancer experience
Klinikdirektor — Senology / Certified Breast Centre, Klinikum Bremen-Mitte
DKG-certified Breast and Gynaecological Cancer Centre leadership
BMBC (Brain Metastases in Breast Cancer Registry) — 4,000+ patient research collaboration
Phase 3 clinical trial investigator (159 academic centres in Germany, France, Australia, Austria, UK)

Qualifications & Credentials

Medical Degrees

Doctor of Medicine (Dr. med.) — Germany
Specialist (Facharzt) in Gynaecology and Obstetrics — Germany
Subspecialty in Senology (Breast Surgery) — Germany
Subspecialty in Gynaecological Oncology — Germany

Fellowships & Special Training

Specialised training in DKG-certified Breast Centre leadership
Specialised training in advanced breast cancer surgery and oncoplastic procedures
Specialised training in gynaecological oncology surgery
Active participation in Brain Metastases in Breast Cancer Registry (BMBC) research
HTG EdgeSeq Oncology Biomarker Panel research (molecular profiling)

Certifications & Accreditations

German Medical Association — Board Certified Specialist in Gynaecology and Obstetrics with Senology subspecialty
Klinikum Bremen-Mitte Breast and Gynaecological Cancer Centre — Certified by Deutsche Krebsgesellschaft (DKG, German Cancer Society)
First Certification: 13 August 2003; Latest Recertification: 09 May 2025; Validity: until 19 December 2028
Working Group of Gynaecological Oncology (AGO) — Member

Areas of Expertise

Major Conditions Treated

Breast Cancer (All Subtypes)
Brain Metastases from Breast Cancer
Recurrent and Metastatic Breast Cancer
Hereditary Breast and Ovarian Cancer (BRCA-positive)
Ovarian Cancer (Recurrent and Advanced)
Endometrial (Uterine) Cancer
Cervical Cancer
Vulvar and Vaginal Cancer
Benign Breast Diseases
Pre-Cancerous Cervical Lesions

Sub-specialties

Senology (Breast Surgery): DKG-certified Breast Centre leadership — patients seeking the best Surgical Oncology doctor in Germany for breast cancer in Bremen consult Dr. Aydogdu as Klinikdirektor of the certified Bremen-Mitte Breast Centre.
Gynaecological Oncology: Comprehensive surgical management of ovarian, endometrial, cervical, vulvar, and vaginal cancers.
Brain Metastases in Breast Cancer Research: Active investigator in BMBC Registry with molecular profiling using HTG EdgeSeq Oncology Biomarker Panel.
Recurrent Ovarian Cancer Trials: Phase 3 clinical trial investigator on bevacizumab combinations.

Advanced Procedures & Treatments

Modified Radical Mastectomy
Skin-Sparing and Nipple-Sparing Mastectomy
Breast-Conserving Surgery
Oncoplastic Breast Surgery
Sentinel Lymph Node Biopsy
Breast Reconstruction (Implant-Based and Autologous)
Radical Hysterectomy
Ovarian Cytoreductive Surgery
Radical Vulvectomy
Endometrial Cancer Surgery
Chemotherapy Coordination (including Bevacizumab regimens)
Targeted Therapy and Immunotherapy
Multidisciplinary Tumour Board Coordination
HER2 Protein Overexpression Testing and Molecular Profiling

List of Disease and Treatment for which Dr. Mustafa Aydgodu can be consulted

Leukemia Multiple Myeloma

Professional Experience

Current Affiliation

Klinikdirektor (Clinic Director), Senology — Klinikum Bremen-Mitte, Brust- und Gynäkologisches Krebszentrum, St.-Jürgen-Straße 1, 28205 Bremen, Germany (Present)
Centre Director — Brust- und Gynäkologisches Krebszentrum (Breast and Gynaecological Cancer Centre)

Past Affiliations

Earlier roles in German breast and gynaecological oncology centres prior to Bremen-Mitte directorship

Academic & Research Roles

Co-investigator — Brain Metastases in Breast Cancer Registry (BMBC) — 4,000+ BC patients with brain metastases, 400 tumour tissue samples
Co-author on HTG EdgeSeq Oncology Biomarker Panel research
Phase 3 clinical trial investigator — bevacizumab combinations in recurrent ovarian cancer (159 academic centres across Germany, France, Australia, Austria, UK)
Active speaker at German breast and gynaecological cancer conferences

Key Achievements

29+ years of senology and gynaecological oncology experience
Klinikdirektor of DKG-certified Breast and Gynaecological Cancer Centre at Klinikum Bremen-Mitte
BMBC Registry research collaboration — landmark German breast cancer brain metastases study
Multi-country Phase 3 clinical trial investigator in recurrent ovarian cancer
Continuous DKG re-certification of breast and gynaecological cancer centres under his leadership

Awards & Recognitions

National & International Awards

DKG-Certified Breast Centre — Klinikum Bremen-Mitte (under Dr. Aydogdu's directorship)
DKG-Certified Gynaecological Cancer Centre — Klinikum Bremen-Mitte

Professional Memberships

German Cancer Society (Deutsche Krebsgesellschaft, DKG)
Working Group of Gynaecological Oncology (AGO)
German Society of Gynaecology and Obstetrics (DGGG)
German Society of Senology

Research & Publications

Published Papers (Selected)

Co-author on the Brain Metastases in Breast Cancer Registry (BMBC) research — collaboration with E. Laackmann, K. Riecke, S. Rachakonda, V. Müller, I. Witzel, M. Schmidt, K. Junker, P. A. Fasching, L. Oliveira-Ferrer, P. Jank, K. Lübbe, M. M., and others.
Co-author — Multicentre, open-label, randomised, Phase 3 trial comparing bevacizumab-containing regimens versus carboplatin–pegylated liposomal doxorubicin combined with bevacizumab in recurrent epithelial ovarian, primary peritoneal, or fallopian tube carcinoma — across 159 academic centres in Germany, France, Australia, Austria, and the UK.
Multiple ResearchGate publications on breast cancer molecular profiling and gynaecological oncology.

Ongoing Research & Clinical Interests

Brain metastases in breast cancer (BMBC Registry)
HTG EdgeSeq Oncology Biomarker Panel and molecular profiling
Bevacizumab and targeted therapy combinations in recurrent ovarian cancer
HER2-directed therapy and Absolute Intrinsic Molecular Subtyping
Certified breast centre quality standards

Estimated Treatment Costs

Procedure / Consultation	Estimated Cost (INR)	Estimated Cost (USD)
Senology / Gynaecological Oncology Consultation (Germany)	₹40,000 – ₹80,000	$480 – $960
Modified Radical Mastectomy (full package)	₹8,00,000 – ₹16,00,000	$9,600 – $19,200
Breast-Conserving Surgery with Reconstruction	₹10,00,000 – ₹20,00,000	$12,000 – $24,000
Oncoplastic Breast Surgery	₹12,00,000 – ₹22,00,000	$14,400 – $26,500
Radical Hysterectomy / Ovarian Cytoreduction	₹14,00,000 – ₹28,00,000	$16,800 – $33,500
Bevacizumab + Chemotherapy (per cycle)	₹4,00,000 – ₹8,00,000	$4,800 – $9,600
Targeted Therapy / Immunotherapy (per cycle)	₹4,50,000 – ₹9,00,000	$5,400 – $10,800

*Indicative estimates only. Actual costs in Germany vary substantially from Indian rates and depend on hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.

Frequently Asked Questions

1. What advanced technologies does Dr. Mustafa Aydogdu use in Surgical Oncology and Breast Cancer treatment?

Dr. Mustafa Aydogdu uses advanced senology surgical techniques (oncoplastic, skin-sparing, nipple-sparing mastectomy), breast reconstruction, sentinel lymph node biopsy, radical gynaecological cancer surgery, modern HER2 protein overexpression testing, HTG EdgeSeq Oncology Biomarker Panel molecular profiling, bevacizumab-based targeted chemotherapy, immunotherapy, and integrates multidisciplinary tumour board care at the DKG-certified Bremen-Mitte Breast Centre.

2. What conditions does Dr. Mustafa Aydogdu specialize in treating?

Dr. Mustafa Aydogdu specialises in all subtypes of breast cancer (including brain metastases, hereditary BRCA-positive, recurrent and metastatic disease), ovarian cancer (recurrent and advanced), endometrial, cervical, vulvar, and vaginal cancers, and benign breast diseases. As a leading Surgical Oncology specialist Bremen, Germany, he is widely consulted for DKG-certified centre care.

3. How do I book an appointment with Dr. Mustafa Aydogdu?

Appointments with Dr. Mustafa Aydogdu can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.

4. Can international patients receive treatment from Dr. Mustafa Aydogdu?

Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Mustafa Aydogdu, including medical visa invitation letters, airport transfers, and local accommodation coordination.

5. What support is available for international patients?

International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.

6. Does Dr. Mustafa Aydogdu offer second opinions for Surgical Oncology cases?

Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or surgical plan with an expert DKG-certified Breast Centre Director in Bremen, Germany.

About Dr. Mustafa Aydgodu